Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T17:34:07.036Z.
Calculation as of: 2026-10-06T17:34:07.036Z.
Quote observation: 2026-10-06T17:27:57.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: a4f1da35868143a3e9cc9e15baeeae426ebbcf8636af82277700bcf7ee6cbb8a
EARNINGS YIELD
N/A
Market Cap
$78.31M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$78.07M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$76.37M
Earnings Yield
N/A
TTM Avg
1.77%
3Y Avg
207.61%
5Y Avg
207.61%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Sera Prognostics, Inc. (SERA) | $77.53M | N/A | N/A | N/A | N/A |
| Pulmonx Corporation (LUNG)vs › | $77.08M | N/A | N/A | N/A | N/A |
| Neonc Technologies Holdings, Inc. (NTHI)vs › | $78.31M | N/A | N/A | N/A | N/A |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $78.07M | N/A | N/A | N/A | N/A |
| Hyperfine, Inc. (HYPR)vs › | $76.64M | N/A | N/A | N/A | N/A |
| SkinHealth Systems Inc. (SKIN)vs › | $76.37M | N/A | 1.77% | 207.61% | 207.61% |
| Citius Oncology, Inc. (CTOR)vs › | $79.96M | N/A | N/A | N/A | N/A |
| Outset Medical, Inc. (OM)vs › | $75.35M | N/A | N/A | N/A | N/A |
| Nutriband Inc. (NTRB)vs › | $80.11M | N/A | N/A | N/A | N/A |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $80.90M | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
